Predicate |
Object |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-30 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-1774 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-2046 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-5418 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0034 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-17 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00 |
filingDate |
2018-03-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2020-07-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate |
2020-07-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
KR-102133887-B1 |
titleOfInvention |
PHARMACEUTICAL COMPOSITION FOR THE PREVENTION OR TREATMENT OF HUMAN PAPILLOMAVIRUS-RELATED DISEASES COMPRISING IMMUNOGLOBULIN Fc-FUSED INTERLEUKIN-7 FUSION PROTEIN |
abstract |
The present invention relates to a pharmaceutical composition comprising an immunoglobulin Fc region and an IL-7 fusion protein, specifically, when the fusion protein containing the immunoglobulin Fc region and IL-7 is topically administered, a strong immune response in the body is obtained. Induction, human papillomavirus-derived diseases can be prevented or treated. |
priorityDate |
2015-12-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |